Snake Venom Disintegrins: Natural Products with Antitumor Effect

References (49)

1. 1 Integrins: Versatility, modulation, and signaling in cell adhesion [DOI]
2. 2 Cancer and Radiation Therapy: Current Advances and Future Directions [DOI]
3. 3 Global cancer transitions according to the Human Development Index (2008–2030): a population-based study [DOI]
4. 4 Ligand Binding to Integrins [DOI]
5. 5 Cell–matrix adhesion [DOI]
6. 6 Snake venoms and the hemostatic system [DOI]
7. 7 Hemorrhagic metalloproteinases from snake venoms [DOI]
8. 8 Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases [DOI]
9. 9 Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity [DOI]
10. 10 Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells [DOI]
11. 11 Snake venom disintegrins: evolution of structure and function [DOI]
12. 12 Heterocyclic Scaffolds: Centrality in Anticancer Drug Development [DOI]
13. 13 Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy [DOI]
14. 14 Platinum Compounds: A Hope for Future Cancer Chemotherapy [DOI]
15. 15 Advances in Nano Drugs for Cancer Chemotherapy [DOI]
16. 16 Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives [DOI]
17. 17 Thalidomide: A Banned Drug Resurged into Future Anticancer Drug [DOI]
18. 18 Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. [DOI]
19. 19 Integrins in invasive growth [DOI]
20. 20 Snake venom metalloproteinases: Structure, function and relationship to the ADAMs family of proteins [DOI]
21. 21 Evolution of Disintegrin Cysteine-Rich and Mammalian Matrix-Degrading Metalloproteinases: Gene Duplication and Divergence of a Common Ancestor Rather Than Convergent Evolution [DOI]
22. 22 Contortrostatin, a dimeric disintegrin from contortrix contortrix, inhibits breast cancer progression [DOI]
23. 23 Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication [DOI]
24. 24 Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis [DOI]
25. 25 Inhibition of tumor formation by snake venom disintegrin [DOI]
26. 26 A Novel Snake Venom Disintegrin That Inhibits Human Ovarian Cancer Dissemination and Angiogenesis in an Orthotopic Nude Mouse Model [DOI]
27. 27 Snake Venom: A Potent Anticancer Agent [DOI]
28. 28 Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast [DOI]
29. 29 Effect of VP12 and viperistatin on inhibition of collagen receptors: dependent melanoma metastasis [DOI]
30. 30 Applications of snake venom components to modulate integrin activities in cell–matrix interactions [DOI]
31. 31 Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition [DOI]
32. 32 Regulatory effect of nerve growth factor in 9 1 integrin-dependent progression of glioblastoma [DOI]
33. 33 Echistatin Inhibits the Migration of Murine Prefusion Osteoclasts and the Formation of Multinucleated Osteoclast-Like Cells [DOI]
34. 34 Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation [DOI]
35. 35 Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin [DOI]
36. 36 Ussuristatin 2, a Novel KGD-Bearing Disintegrin from Agkistrodon ussuriensis Venom [DOI]
37. 37 Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential [DOI]
38. 38 The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo [DOI]
39. 39 Effect of the disintegrin eristostatin on melanoma–natural killer cell interactions [DOI]
40. 40 Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris*1 [DOI]
41. 41 Structural and Biologic Properties of Integrin-Mediated Cell Adhesion [DOI]
42. 42 The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model [DOI]
43. 43 Integrin-mediated adhesion and signaling in tumorigenesis [DOI]
44. 44 Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones [DOI]
45. 45 Triflavin, an Arg‐Gly‐Asp‐containing Peptide, Inhibits Tumor Cell‐induced Platelet Aggregation [DOI]
46. 46 Inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells with special reference to implication of ?v integrins [DOI]
47. 47 Antitumor Activity of Disintegrin-Like Components from the Venom of Montivipera raddei [DOI]
48. 48 Identification by Site-directed Mutagenesis of Amino Acid Residues Flanking RGD Motifs of Snake Venom Disintegrins for Their Structure and Function.
49. 49 Editorial [Hot Topic: Nano Drugs: Novel Agents for Cancer Chemo-Therapy (Guest Editor: Imran Ali)] [DOI]

Cited by 1

Related research

• Snake Venom Components as Therapeutic Leads: A Critical Narrative Review of Established Medicines and Translational Barriers — shares topic coverage
• Screening of North African Medicinal Plant Extracts for Cytotoxic Activity Against Tumor Cell Lines — shares topic coverage
• A Review on Metal Complexes and their Anti-Cancer Activities: Recent Advances from In vivo Studies (2017–2023) — shares topic coverage
• Chemotherapy-induced Peripheral Neuropathy: Clinical Features, Differential Diagnosis and Prevention — shares topic coverage
• Computational Investigation of Eugenol–triazole Derivatives Targeting Breast Cancer Proteins — shares topic coverage